Shayesteh Tavakol Heidary, Radmehr Moojan, Khajavi Farzad, Mahjub Reza
Department of Pharmaceutics, School of Pharmacy, Hamedan University of Medical Sciences, Hamedan, Iran.
Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Eur J Pharm Sci. 2015 Mar 10;69:44-50. doi: 10.1016/j.ejps.2014.12.013. Epub 2014 Dec 27.
In this study, the acid dissociation constants (pKa) of some benzodiazepine derivatives including chlordiazepoxide, clonazepam, lorazepam, and oxazepam in aqueous micellar solution were determined spectrophotometrically at an ionic strength of 0.1M at 25°C. The effect of cetyl trimethylammonium bromide (CTAB) as a cationic and sodium n-dodecyl sulfate(SDS) as an anionic surfactant on the absorption spectra of benzodiazepine drugs at different pH values were studied. The acidity constants of all related species are estimated by considering the surfactant concept and the application of chemometric methods using the whole spectral fitting of the collected data to an established factor analysis model. DATAN® software (Ver. 5.0, Multid Analyses AB, and Goteborg, Sweden) was applied to determine the acidity constants. In this study, a simple and fast method to determine the ionization constant (pKa) of poorly soluble drugs was developed using surfactants. The acidity constant (i.e. pKa) for chlordiazepoxide, clonazepam, lorazepam, and oxazepam were reported as 4.62, pKa1 value of 1.52 and pKa2 value of 10.51, pKa1 value of 1.53 and pKa2 value of 10.92 and pKa1 value 1.63 and pKa2 value of 11.21 respectively. The results showed that the peak values in the spectrophotometric absorption spectra of drugs are influenced by the presence of anionic and cationic surfactants. According to the results, by changing the SDS concentration from 0 to 0.05M, the pKa of chlordiazepoxide was increased to 5.9, the pKa1 of lorazepam was decreased to 0.1 while the pKa2 was increased to 11.5. Increase in SDS concentration has not shown significant alteration in pKa of clonazepam and oxazepam. Results indicate that by Changing the CTAB concentration from 0 to 0.05M, the pKa of chlordiazepoxide was reduced to 4.4, the pKa1 of clonazepam was decreased to 0.1 and the pKa2 was decreased to 9.1, the pKa1 of lorazepam was decreased to 0.4 and the pKa2 was decreased to 9.4, the pKa1 of oxazepam was decreased to 0.3 and the pKa2 was decreased to 9.7. Based on the results obtained from the study, charge of anionic and cationic surfactants leads to an electrostatic interaction between surfactant and the protonated form of the drug molecule. The electrostatic interactions can be attractive or repulsive forces and influence of separation of protons and consequently increase or decrease the acidity constants.
在本研究中,于25°C、离子强度为0.1M的条件下,采用分光光度法测定了包括氯氮卓、氯硝西泮、劳拉西泮和奥沙西泮在内的一些苯二氮卓衍生物在水胶束溶液中的酸解离常数(pKa)。研究了阳离子表面活性剂十六烷基三甲基溴化铵(CTAB)和阴离子表面活性剂十二烷基硫酸钠(SDS)在不同pH值下对苯二氮卓类药物吸收光谱的影响。通过考虑表面活性剂概念以及运用化学计量学方法,将收集的数据进行全光谱拟合至既定的因子分析模型,估算了所有相关物种的酸度常数。使用DATAN®软件(版本5.0,Multid Analyses AB,瑞典哥德堡)来测定酸度常数。在本研究中,开发了一种利用表面活性剂测定难溶性药物电离常数(pKa)的简单快速方法。氯氮卓、氯硝西泮、劳拉西泮和奥沙西泮的酸度常数(即pKa)分别报告为4.62、pKa1值为1.52且pKa2值为10.51、pKa1值为1.53且pKa2值为10.92以及pKa1值为1.63且pKa2值为11.21。结果表明,药物分光光度吸收光谱中的峰值受阴离子和阳离子表面活性剂的存在影响。根据结果,将SDS浓度从0改变至0.05M时,氯氮卓的pKa增加至5.9,劳拉西泮的pKa1降至0.1而pKa2增至11.5。SDS浓度的增加未显示氯硝西泮和奥沙西泮的pKa有显著变化。结果表明,将CTAB浓度从0改变至0.05M时,氯氮卓的pKa降至4.4,氯硝西泮的pKa1降至0.1且pKa2降至9.1,劳拉西泮 的pKa1降至0.4且pKa2降至9.4,奥沙西泮的pKa1降至0.3且pKa2降至9.7。基于该研究获得的结果,阴离子和阳离子表面活性剂的电荷导致表面活性剂与药物分子的质子化形式之间产生静电相互作用。静电相互作用可以是吸引力或排斥力,会影响质子的分离,从而增加或降低酸度常数。